Semaglutide reduces HbA<sub>1c</sub> and body weight across baseline HbA<sub>1c</sub> subgroups in the SUSTAIN 1-5 clinical trials - Virtual Meeting | EASD
Sally Bain - Senior Director, Global Media Relations at Sanofi - Cambridge, Massachusetts, United States | LinkedIn
James E. Cecchi [JC7697] Lindsey H. Taylor [LT 7234] CARELLA, BYRNE, BAIN, GILFILLAN, CECCHI, STEWART & OLSTEIN 5 Becker Far
![Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines | Business Wire Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines | Business Wire](https://mms.businesswire.com/media/20220106005600/en/1320769/22/Exscientia_Logo.jpg)